/PSYB.V
PSYB.V Stock - PsyBio Therapeutics Corp.
Healthcare|BiotechnologyTSXV
$0.01-25.00%
$0.00 (-25.00%) • Nov 24
53
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.94
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PSYB.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.66
52W High$0.14
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-50,000 | $-62,500 | $-1,535,000 | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-4,555,000 | $-9,043,000 | $-6,436,000 | $-38,972 | $-20,860 |
| Net Income | $-4,886,000 | $-11,019,000 | $-6,436,000 | $-16,158 | $-20,861 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.04 | $-0.10 | $-0.20 | $0.00 | $-0.01 |
Company Overview
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PSYB.VBeat Rate
25%
Last 4 quarters
Avg Surprise
-55.7%
EPS vs Estimate
Beats / Misses
1/3
Last 12 quarters
Latest EPS
$-0.00
Q2 2023
EPS Surprise History
Q4 21
-100.0%
$-0.02vs$-0.01
Q1 22
-99.9%
$-0.03vs$-0.01
Q2 22
+12.2%
$-0.02vs$-0.02
Q3 22
-35.0%
$-0.01vs$-0.01
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.02 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 29, 2022 | $-0.01 | $-0.01 | -35.0% | ✗ MISS |
Q2 2022 | May 30, 2022 | $-0.02 | $-0.02 | +12.2% | ✓ BEAT |
Q1 2022 | Mar 3, 2022 | $-0.01 | $-0.03 | -99.9% | ✗ MISS |
Q4 2021 | Nov 29, 2021 | $-0.01 | $-0.02 | -100.0% | ✗ MISS |
Q3 2021 | Jul 14, 2021 | — | $-0.04 | — | — |
Q2 2021 | Jun 1, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.04 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PSYB.V
What is PSYB.V's current stock price?
PsyBio Therapeutics Corp. (PSYB.V) is currently trading at $0.01 per share. The stock has moved -25.00% today.
What is the analyst price target for PSYB.V?
No analyst price targets are currently available for this stock.
What sector is PsyBio Therapeutics Corp. in?
PsyBio Therapeutics Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the TSXV exchange.
What is PSYB.V's market cap?
PsyBio Therapeutics Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does PSYB.V pay dividends?
No, PsyBio Therapeutics Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCGN.CN
Cognetivity Neurosciences Ltd.
$0.01
Mkt Cap: $0.0B
CZO.V
Ceapro Inc.
$0.23
Mkt Cap: $0.0B
HAVN.CN
HAVN Life Sciences Inc.
$0.03
Mkt Cap: $0.0B
IWIN.CN
Irwin Naturals Inc.
$0.30
Mkt Cap: $0.0B
J.CN
Lotus Ventures Inc.
$0.01
Mkt Cap: $0.0B
NEWU.V
Newtopia Inc.
$0.01
Mkt Cap: $0.0B
NHP.V
Lumiera Health Inc.
$0.01
Mkt Cap: $0.0B
RP.V
RepliCel Life Sciences Inc.
$0.01
Mkt Cap: $0.0B
SVS.V
Solarvest BioEnergy Inc.
$0.02
Mkt Cap: $0.0B
TREE.NE
Trees Corporation
$0.01
Mkt Cap: $0.0B
Explore stocks similar to PSYB.V for comparison